Viewing Study NCT06492187



Ignite Creation Date: 2024-07-17 @ 11:40 AM
Last Modification Date: 2024-10-26 @ 3:34 PM
Study NCT ID: NCT06492187
Status: RECRUITING
Last Update Posted: 2024-07-09
First Post: 2024-07-01

Brief Title: Triage Survey for Infectious Disease Eligibility
Sponsor: Brooklyn Clinical Research
Organization: Brooklyn Clinical Research

Study Overview

Official Title: Triage Survey for Infectious Disease Eligibility SWIFT-ID-101
Status: RECRUITING
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: SWIFT-ID-101 is a single site survey study designed to assess potential participants eligibility to screen for industry-sponsored clinical trials for diagnosis treatment or prevention of infectious diseases such as in the areas of HIV vaccines and other infectious-diseases areas A physician will oversee the informed consent process after which participants will be surveyed on demographics medicalsurgical history physical examination comorbidities and any current symptoms Informed consent will be done electronically preferable or on paper Informed consent may be done in-person or remotely depending on patient preference Information related to HIV hepatitis B and C other infectious diseases or substance use disorder will also be obtained if applicable Site staff may collect vital signs fingerpick testing urine drug screens blood draws EKG and pregnancy tests Some testing may be recommended in a fasting condition A doctor will review medical history and results of the above evaluations with the participant to determine study suitability via clinical interview The doctor may reach out to the patients current treating physicians other providers and pharmacies to determine eligibility for clinical trials A follow-up phone call may be needed to discuss testing results andor trial eligibility If a participant is deemed eligible for future trials and if the participant remains interested counseling on contraception requirements for trials will be discussed
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None